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Abstract
The cannabis plant was discovered 10,000 years ago without its exact use being known in China and Central Asia. 
Equally highly interested in this plant are the pharmaceutical and construction sectors. The cultivation of Cannabis 
sativa L. varieties containing more than 0.2% tetrahydrocannabinol (THC) has been legalized by the law 4523/2018 in 
Greece for the sole purpose of producing end-products of medicinal cannabis. The use of medicinal cannabis is important 
for dealing with chronic diseases. As far as cannabis cultivated for industrial use is concerned, there is a significant 
increase in the secondary services sector. The resulting fibers are used for the manufacture of ropes etc. Especially 
CBD is of great interest. Through surveys carried out by the Agronomy Laboratory of Agricultural University of Athens 
regarding the development of cannabis by applying geotextiles, radiation management, cannabidiol (CBD) content and 
tetrahydrocannabinol (THC), statistical data have been compiled for cannabis cultivation both pharmaceutical and textile. 
On the basis of the results, cannabis can be grown in Greece due to the weather conditions and, above all, sunshine, which 
is the main factor for the development of the plant. 
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Introduction
Historical review
Cannabis sativa L. is a plant widely distributed 
all over the world (Hartsel et al., 2016). Cannabis 
belongs to the oil-fiber plants and the species 
Cannabis sativa L. was used from the Neolithic 
period to produce numerous products and by-
products. In Greece, hemp has been cultivated for 
centuries for production cords and fabrics - the 
first mention of it is found in 450 BC, to Herodotus. 
In the mid-20th century, cannabis was a major 
agricultural commodity cultivation and exportable 
product. It is characteristic that, until 1957, when 
cannabis cultivation was prohibited, there were 
seven factories operating in Greece that processed 
fiber to make ropes. During this period immigrants 
from Egypt, Cyprus and countries from the Middle 
East lived moved to the port because of work 
(Stefanis, 1975). In 1906, the Greek government introduced customs restrictions and tax on 
cannabis cultivation, accepting British pressures, 
extinguishing the Greek grapes market. With the 
end of World War I the industrial cannabis was a 
basic agricultural crop and exportable product in 
1932 (Papadopoulos, 1974).
In 2017 in Europe, the total cultivated area 
of cannabis for production hempseed reached 
19,478 ha. and the area harvested about hemp 
tow waste was 11,700 ha (FAO, 2018).  The last 
five years has seen a threefold increase in its area 
of cultivation Europe. 
Chemotype of cannabis
C. sativa is characterized by a complex che-
mical composition, including terpenes, carbohy-
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drat es, fatty acids and their esters, amides, ami-
nes, phytosterols, phenolic compounds, and the 
specific compounds of this plant, namely, the 
cannabinoids (Andre et al., 2016). The main ingre-
dients of cannabis are Cannabinoids which are 
best-known for their healing effect and include 
Cannabidiol-CBD and tetrahydrocannabinol-Δ-9-
THC. They have been identified and isolated from 
hemp about 60 cannabinoid compounds, most of 
which are found in very little ratio (Sikora et al., 
2011).
Some of the cannabinoids come from raw 
cannabis and others are produced after heating, 
some we find them more in the bud of the 
blooming plant or before the plant blossomed and 
there is also the possibility to appear only after 
it drying out. The characteristic fragrance in the 
plant comes from terpenoids.
Cannabidiol (CBD) is found in 0.5-2% in 
the upper 1/3 of the plant and has studied 
for its therapeutic effect on cancer, diabetes, 
Alzheimer’s, epilepsy etc. The THC: CBD ratio is 
used to characterize the cannabis under study in 
pharmaceutical or not (Mechtler et al., 2004). There 
are three cannabis chemotypes: the drug type, 
the fibre type and the intermediate type, which 
is easily distinguished by their Δ-9-THC content, 
that represent the psychoactive constituent of the 
cannabis plant. The drug type is characterized by 
a high Δ-9-THC content (>2%), high in resin and 
is mainly found in good climatic conditions areas 
and sufficient sunshine. The fibre type has a low 
Δ-9-THC content (<0.5%) as opposed to high CBD 
content (>0.5%) and is cultivated for paper, cloth 
and litter production. The Δ-9-THC content in the 
fibre type doesn’t exceed 0.03%. Intermediate 
type characterized by the high content of Δ-9-THC 
and CBD (>0.5%) (Kinghorn, 2017).
Classification of cannabis by chemotype 
according to the below ecuation: Chemotype I 
(drug-type) cultivars are characterized by X values 
greater than 1, whereas values lower than 1 are 
representative of chemotype III cultivars (fiber-
type) (Hartsel et al., 2016)
Where: CBN: Cannabinol, CBD: Cannabidiol and 
THC: tetrahydrocannabinol 
Legislation in Greece
The cultivation of Cannabis sativa L. for 
medical uses was legalized in Greece in March of 
2018 with a tetrahydrocannabinol (THC) content 
greater than 0.2%. The supporting documents for 
set up license and operating license are valid for 5 
years and 10 years, respectively. Any amendments 
require new supporting documents. On the basis 
of legislation, the cultivation will take place under 
enclosed conditions (greenhouse or indoor), the 
whole productive area must be fenced-off and 
there are private security guards. The quantity of 
propagating material introduced is limited, up to 
30 kg of seed per hectare. Also, the greenhouse 
location in the field should be 1000 meters away 
from schools, archeological areas etc. (Regulation 
Gazette No. 6591, 2018). Also, according to the 
Law 929Β/6-4-2016 fiber cannabis cultivation 
is permitted for cannabis varieties with a THC 
content < 0.2% and listed in the National & 
European Community Catalog (Regulation Gazette 
No. 929 B, 2016).
Materials and Methods
The Agronomy Laboratory of the Agricultural 
University of Athens has carried out various research projects on medical cannabis and 
industrial hemp. Research in medical cannabis 
is subject to national restrictions by law, while 
several field experiments have been conducted in 
industrial hemp. The Laboratory has undertaken 
more than 20 projects (European, National and 
private sector) related to cannabis, as well as 
the processing of dossiers for setup enterprise 
units licensing by the Government. Also, we are 
members of editing team for the law regarding canabis cultivation.
Results and discussions
Climatic conditions
Greece is characterized by predominant 
Mediterranean climate, with mean annual 
temperatures ranging from 14 to 22°C. Most of 
Greece regions meet the demands of cannabis 
cultivation. Considering crop’s requirements 
(temperature, photoperiod or light duration), in 
a case of green house facility, in order to exploit 
natural resources to the most, the suggested 
sites include the whole region from Central and 
West Greece to South Greece, of mainland. More 
particularly, the regions Thessaly, Central Greece 
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and Peloponnese, are to be preferred (Folina et al., 
2019).
Pharmaceutical cannabis
The medicinal cannabis is compulsorily grown 
in a greenhouse due to the final product concerned 
with a type of drug. Greenhouse cannabis crop 
production is based on control of the environment 
in such a way as to provide the conditions that are 
most favorable for maximum yield. The location 
of the greenhouse and its orientation are factors 
that greatly influence the production potential. 
Solar radiation during winter, temperature, wind 
and soil are needed to evaluate the suitability of 
a region (Mavrogiannopoulos, 2017). A region 
with high amount of sunlight can significantly 
reduce the use of technical light and therefore 
the cost, since the lighting constitutes the 50% 
of final product cost. With regard to temperature, 
there are many areas in Greece where there are 
relatively high minimum temperatures in the 
winter and low maximum in the summer (Folina 
et al., 2019).
Through our research, we have developed 
green house expertise in the production of pharma-
ceutical cannabis. On the product line, plant 
growth, harvest and other grow development 
issues (irrigation, CO
2
 enrichment, lighting types 
(LED or HPS), duration of light, fertilization, 
trimming etc.). For measuring the THC and CBD 
content in cannabis, we use the GemmaCert device 
machine (Fig. 1).
Industrial cannabis
Industrial cannabis thrives in all soils but is 
extremely sensitive to heavy, saturated soils and 
soils with pH < 6.0 should be avoided. Its sowing 
takes place from mid-March onwards when the 
ground temperature is 12-14°C and not lower than 
6-8°C. It is proposed to be included in the program 
crop rotation because it has a beneficial role in 
yielding the next crop in particular when it comes 
to cereals (Amaducci et al., 2014). Fiber cannabis 
is very sensitive to environmental conditions 
such as photoperiod and temperature (day/
night temperature) (Angelini et al., 2016). Fiber 
hemp and its products are used in a wide range 
of industries and textiles (Salentijn et al., 2015) 
while at the same time its cultivation as an energy 
plant has been promoted in recent years due to the 
                
Figure 1. Device for measuring THC and CBD in cannabis flower by GemmaCert Ltd 
(Personal photo, archive of Prof. Dimitrios Bilalis)
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Figure 2. Industrial cannabis cultivation 
(Personal photo archive of Prof. Dimitrios Bilalis)
                       
Figure 3. Processing of industrial cannabis for receiving CBD 
(Personal photo archive of Prof. Dimitrios Bilalis)
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tall cellulose content (about 60%) and low lignin 
content (about 7-8%) (Cappelletto et al., 2011). 
Cannabis fibers are still used for the construction 
of insulation and building materials. Cannabis fiber 
constructions are used in the automotive industry 
as insulators and car waterproofing (Struik et 
al., 2000). The content of secondary metabolites 
such as inflorescences and leaves cannabinoids 
is a promising end-use area of industrial hemp 
(Cappelleto et al, 2011). 
In industrial cannabis we have done a lot 
of experiments, either in the field or in the 
greenhouse. In a greenhouse experiment we placed 
a different color of geotextiles (white and black) so 
that we could observe different plant growth, CBD 
percentage and light reflection in each case. Also, 
a topping experiment was conducted to evaluate 
its effect on the concentration of CBD in cannabis 
buds. A major experiment was carried out in 
mainland Greece where industrial cannabis was 
cultivated in 50 plots where we sampled CBD for 
study and analysis (Figs. 2, 3).
Conclusions
Any discussion that was made a few years 
ago was considered prohibitive. The cultivation of 
medicinal and industrial cannabis takes place in 
Greece and offers tremendous opportunities for 
producers as well as the domestic economy. One 
of the most important advantages of the cannabis 
industry is the need for human resources, thus 
job creation. For example, to meet the needs of a 
hectare of cannabis 50 scientific or technical staff is 
needed. Greece has so far approved 26 enterprise 
licenses for the production of pharmaceutical 
cannabis with total setup cost more than 350 
million €. Total application more than 72 and there 
are under evaluation with total set up cost more 
than one billion €. This moment 40 hectares are 
cultivated with industrial cannabis, both for the 
harvest of flowers and for the CBD oil or seed oil. 
Greece’s competitive advantage is the high-quality 
industrial hemp that we can produce because of 
its climate, soil and geographical location. Europe 
is making significant imports of industrial hemp 
(mainly from China) to meet its increased needs. 
For instance, Europe imports half its seeds, while 
a very small proportion of its seeds are organic. 
There, Greece can play a very important role, as 
in the production of quality fibers, but also in 
ecological materials. Greece occupies an important 
place in the European Union in cannabis cultivation 
and is a strategic entry point into the fast-growing 
European territory, with a population of more 
than 740 million. It has both the specifications 
and the prospect of becoming a country producing 
high quantities of pharmaceutical and industrial cannabis.
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